bioRxivBioengineering
In vivo Biomedical Imaging of Immune Tolerant, Radiopaque Nanoparticle-Embedded Polymeric Device Degradation
Abstract
Biomedical implants remain an important clinical tool for restoring patient mobility and quality of life after trauma. While polymers are often used for devices, their degradation profile remains difficult to determine post-implantation. CT monitoring could be a powerful tool for in situ monitoring of devices, but polymers require the introduction of radiopaque contrast agents, like nanoparticles, to be distinguishable from native tissue. As device function is mediated by the immune system, use of radiopaque nanoparticles for serial monitoring therefore requires a minimal impact on inflammatory response. Radiopaque polymer composites were produced by incorporating 0-20wt% TaOx nanoparticles into synthetic polymers: polycaprolactone (PCL) and poly(lactide-co-glycolide) (PLGA). In vitro inflammatory response to TaOx was determined by monitoring mouse bone marrow derived macrophages on composite films. Nanoparticle addition stimulated only a slight inflammatory reaction, namely increased TNF secretion, mediated by changes to the polymer matrix properties. When devices (PLGA 50:50 + 20wt% TaOx) were implanted subcutaneously in a mouse model of chronic inflammation, no changes to device degradation were noted although macrophage number was increased over 12 weeks. Serial CT monitoring of devices post-implantation provided a detailed timeline of device structural collapse, with no burst release of the nanoparticles from the implant. Changes to the device were not significantly altered with monitoring, nor was the immune system ablated when checked via blood cell count and histology. Thus, polymer devices incorporating radiopaque TaOx NPs can be used for in situ CT monitoring, and can be readily combined with multiple medical imaging techniques, for a truly dynamic view biomaterials interaction with tissues throughout regeneration, paving the way for a more structured approach to biomedical device design.
- organism: mouse
- assay: imaging
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Incorporating Radiopacity into Implantable Polymeric Biomedical Devices for Clinical Radiological Monitoring
K. M. Pawelec, E. Tu, … E. Shapiro·Advanced Healthcare MaterialsPeer-reviewed·Mar 13, 2023
- Material Composition and Implantation Site Affect in vivo Device Degradation Rate
Kendell M. Pawelec, Jeremy M.L. Hix, … Erik M. Shapiro·Communications MaterialsPeer-reviewed·Jul 24, 2026
- Radiopaque Implantable Biomaterials for Nerve Repair
K. M. Pawelec, J. M. L. Hix, E. M. Shapiro·bioRxiv·Jan 5, 2023
- Computed Tomography of Polymeric Biomedical Implants from Bench to Bedside
K. Pawelec, T. Schoborg, E. Shapiro·bioRxiv·Feb 20, 2024
- Distinct Roles of Surface Nanostructure and Polymer Degradation in Fibroblast Response to Device Design
Kendell M. Pawelec, Erik M. Shapiro·Biomedical Materials & DevicesPeer-reviewed·Mar 24, 2026
- Device Design and Diagnostic Imaging of Radiopaque 3D Printed Tissue Engineering Scaffolds
M. Delemeester, K. Pawelec, … E. Shapiro·bioRxiv·Feb 26, 2024